×

Follicular Lymphoma Market Report


Company Analysis, History and Future Overview, Global Sales Trends by 2025


Published Date: 2019-06-20   |   Pages: Ongoing   |   Tables: Ongoing   |  Report ID: 7239 |  Industry: Life Science  |   Format : pdf word ppt excel



   Request Sample     Request Customization    Request Methodology
  • SELECT LICENSE TYPE :

  •   Single License
  •  Multi User License
  •  Corporate License


Follicular lymphoma appears in approximately 10-20% of all lymphomas diagnosed in the West. It is the second-most frequently occurring non-Hodgkin lymphoma and has a small predominance in women. The median age at the time of diagnosis of follicular lymphoma is 60 years. Follicular lymphoma therapeutic approaches have been substantially changed in the recent time due to the availability of rituximab. This has resulted in R-chemo becoming the standard induction first-line treatment for follicular lymphoma. The median overall survival is considered to be partly improved because of the advent of rituximab. Follicular lymphoma treatments range from a ‘watch and wait’ policy to hematopoietic stem cell transplantation.

According to a new study by researchers from the University of Texas MD Anderson Cancer Center, compared to the approach of observation, minimally toxic first-line therapies could be more beneficial for patients with early-stage extranodal follicular lymphoma. The study was published early in 2019 in the peer-reviewed journal Clinical Lymphoma, Myeloma & Leukemia. The introduction of new therapies is anticipated to create a number of growth opportunities in the global follicular lymphoma treatment market.

Market Dynamics

Factors such as high number of follicular lymphoma cases and family history of the disease are foreseen to fuel the demand in the global follicular lymphoma treatment market. In addition, the growing prevalence of blood disorders across the world is prophesied to highlight the global market in the coming years. Furthermore, technological development in the diagnosis of follicular lymphoma is predicted to set the tone for substantial growth of the global market. However, the danger of adverse side effects associated with certain follicular lymphoma treatments, expensive cost of treatment, and tight regulatory conditions are expected to restrict the global market growth.

Market Segmentation

By Treatment

   Radiation

   Targeted Therapy

   Chemotherapy

   Others

By End User

   Hospitals

   Clinics

   Specialty Centers

   Cancer Research Institutes

Among treatments, targeted therapy is expected to account for a significant share of the global follicular lymphoma treatment market. The use of monoclonal antibodies and other targeted therapies is considered to be a better approach to the treatment of follicular lymphoma, compared to radiation and chemotherapy. Targeted therapies are used to directly target tumor cells and strengthen immune cells in the patient’s body. If end users of follicular lymphoma treatment are taken into account, hospitals are anticipated to collect a remarkable share of the global market.

By Region

world_regions

The increasing incidence of follicular lymphoma is foretold to push the growth of North America in the global follicular lymphoma treatment market. The region could also witness a rise in its market growth due to increasing investments in research and development for the introduction of new drugs in the industry. Asia Pacific, on the other hand, is projected to show considerable growth in the global market because of the rising number of government initiatives to prevent different types of cancer.

Key Players

The report includes deep analysis of leading companies operating in the global follicular lymphoma treatment market such as Roche, Bayer AG, Spectrum Pharmaceuticals, Bristol-Myers Squibb, Johnson and Johnson, Pharmacyclics, CTI Biopharma, Seattle Genetics, Celgene, Merck & Co., AbbVie Inc., Amgen, and Novartis.

Research Methodology

For an encyclopedic assessment of the global follicular lymphoma treatment market, QY Research has provided verifiable projections about the market size, historical data, and deep qualitative and quantitative insights. The researchers have used near-accurate assumptions and proven research methodologies to derive different projections related to the global market such as CAGR, value, and volume as well as the market growth of regional and segmental markets. The research study serves as a repository of intelligent analyses of the global market, including manufacturing cost analysis, Porter’s Five Forces analysis, SWOT analysis, company analysis, and demand and supply analysis.

Reasons to Buy this Report

  • For exclusive data on the global follicular lymphoma treatment market provided in QY Research’s latest research report
  • For authentic forecasts pertaining to capacity, production, value, consumption, growth rate (CAGR), market share, and milestones so far
  • For a valuable insights into manufacturers, capacity, production, revenue, market share, and recent developments
  • For identifying significant trends, drivers, global influence factors, and regions.

Life sciences is a wide branch of study that is gradually becoming an integral industry to the global economics. QYR Consulting looks at the steady transformation of the life sciences industry and its impact on the subindustries such as medical care, pharmaceutical, and medical devices. Our team of esteemed analysts have put together reports to analyze the monumental changes life sciences is expected to bring in the overall healthcare industry. These reports identify the exact turning points for the industry and open up a platform for discussing its growth.

QYR Consulting brings to you a structured analysis of the technological advancements so far, vision of the players in the industry, and the strategies they are likely to use to make their mark. The reports dissect various components of the life sciences industry to scrutinize the influential factors. To help the readers make profitable business decisions, analysts have highlighted the lucrative investment areas and upcoming business opportunities.

Request for Table of Contents



  You must accept our privacy policies before submit your requirement




Why QYR Consulting?


We are committed to delivering the best solutions and we offer a 24*7 helpline.


We promise superior quality of authenticated data.


We offer help and advice across varying time zones.


We boast a strong team of experienced analysts.


We have an exhaustive repository of published reports.


Read More

Contact us Directly

USA
 +1 626 428 8800

India
  +91 20 67104444

Beijing
  +86 108 294 5717

For Enquiry : sales@qyrconsulting.com

Request for Tables



  You must accept our privacy policies before submit your requirement




Why QYR Consulting?


We are committed to delivering the best solutions and we offer a 24*7 helpline.


We promise superior quality of authenticated data.


We offer help and advice across varying time zones.


We boast a strong team of experienced analysts.


We have an exhaustive repository of published reports.


Read More

Contact us Directly

USA
 +1 626 428 8800

India
  +91 20 67104444

Beijing
  +86 108 294 5717

For Enquiry : sales@qyrconsulting.com

Request for Figures



  You must accept our privacy policies before submit your requirement




Why QYR Consulting?


We are committed to delivering the best solutions and we offer a 24*7 helpline.


We promise superior quality of authenticated data.


We offer help and advice across varying time zones.


We boast a strong team of experienced analysts.


We have an exhaustive repository of published reports.


Read More

Contact us Directly

USA
 +1 626 428 8800

India
  +91 20 67104444

Beijing
  +86 108 294 5717

For Enquiry : sales@qyrconsulting.com

Reasons to Buy this Report



Fastest report delivery

Fastest report delivery

We have the fastest report delivery service with excellent after-sales support

 

In-depth analysis

In-depth analysis

We provide a comprehensive and in-depth analysis in every report that we sell

 

Large database

Large database

We own large database which will help our clients to get customized and syndicated research reports

 

Accurate data

Accurate data

To offer you accurate data, our seasoned analysts will be available to assist you

 


 

Ask a Question

Get in touch with us to find answers to all your business-related queries for fast results.

 

NOTE - The analysis, thoughts, views, facts, and opinions expressed in this report are of the respective research analysts. QYR Consulting does not necessarily endorse it or it is also not essentially formal views of QYR Consulting.



Follicular Lymphoma Market Report